• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[非甾体抗炎药治疗的心血管风险]

[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment].

作者信息

Schmidt Morten, Fosbøl Emil Loldrup, Torp-Pedersen Christian, Olsen Anne-Marie Schjerning, Christensen Bo, Gislason Gunnar H

出版信息

Ugeskr Laeger. 2016 Dec 26;178(52).

PMID:28041549
Abstract

Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs. Current evidence supports that all NSAIDs increase the risk of heart failure and elevate blood pressure, whereas the risk of thrombotic events varies with the type of drug. Use of newer selective cyclooxygenase-2 inhibitors has been associated with a substantial vascular risk but increasing concern also relates to traditional NSAIDs, in particular diclofenac. This review summarizes the current evidence regarding the cardiovascular safety of NSAIDs and presents recommendations for their use.

摘要

非阿司匹林类非甾体抗炎药(NSAIDs)是使用最为广泛的药物之一。目前的证据表明,所有NSAIDs都会增加心力衰竭风险并升高血压,而血栓形成事件的风险则因药物类型而异。新型选择性环氧化酶-2抑制剂的使用与重大血管风险相关,但人们对传统NSAIDs,尤其是双氯芬酸的担忧也在增加。本综述总结了有关NSAIDs心血管安全性的当前证据,并提出了使用建议。

相似文献

1
[Cardiovascular risks of non-steroidal anti-inflammatory drugs treatment].[非甾体抗炎药治疗的心血管风险]
Ugeskr Laeger. 2016 Dec 26;178(52).
2
Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk.环氧化酶-2抑制剂、非甾体抗炎药与心血管风险
Intern Med J. 2006 May;36(5):308-19. doi: 10.1111/j.1445-5994.2006.01056.x.
3
NSAIDs and serious cardiovascular disorders: especially cox-2 inhibitors and diclofenac.非甾体抗炎药与严重心血管疾病:尤其是环氧化酶-2抑制剂和双氯芬酸。
Prescrire Int. 2016 Jan;25(167):14-6.
4
Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs.非甾体抗炎药的心血管效应
Curr Cardiol Rep. 2016 Mar;18(3):25. doi: 10.1007/s11886-016-0702-4.
5
Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.非甾体抗炎药的使用与心房颤动或房扑风险:基于人群的病例对照研究。
BMJ. 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.
6
Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.环氧化酶-2抑制剂和传统非甾体抗炎药的心血管风险。
Ann Med. 2007;39(1):18-27. doi: 10.1080/07853890601073445.
7
[Are there any differences in the cardiovascular tolerance between classical NSAIDs and coxibs?].[传统非甾体抗炎药与环氧化酶-2抑制剂在心血管耐受性方面是否存在差异?]
Presse Med. 2006 Sep;35(9 Spec No 1):1S25-34.
8
Diclofenac use and cardiovascular risks: series of nationwide cohort studies.双氯芬酸的使用与心血管风险:一系列全国性队列研究
BMJ. 2018 Sep 4;362:k3426. doi: 10.1136/bmj.k3426.
9
[Cardiovascular safety of non-steroidal anti-inflammatory drugs].[非甾体抗炎药的心血管安全性]
Tidsskr Nor Laegeforen. 2015 Mar 24;135(6):542-6. doi: 10.4045/tidsskr.14.1269.
10
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib.使用布洛芬、萘普生或氯美昔布治疗的高危骨关节炎患者的心血管结局
Ann Rheum Dis. 2007 Jun;66(6):764-70. doi: 10.1136/ard.2006.066001. Epub 2007 Apr 5.